It is more appropriate to call diabetic complications as MDS-related target organ damage (TOD), since their development involves not only hyperglycemia but also other metabolic disorders of MDS, promoting an up-to-date management philosophy
Modern GLP-1 and GIP medications are designed to mimic or enhance the effects of these hormones, helping patients achieve better control over blood sugar and reducing the risk of cardiovascular and kidney complications
Serial measurements taken under consistent conditions (same time of day, same fasting state) are more informative than single measurements
So tbdfit.com also on my podcast, which we're gonna have you on here momentarily, is the TBD Fit podcast
But once youre pregnant, the official guidance is to stop taking the medication
PubMed Randomized trialNAD+ and precursor evidence2021 Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women Human NMN source for metabolic claims while keeping population limits clear